ArticleBMC medicine2022

Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.

Blossom Mak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.